Results 141 to 150 of about 2,738 (166)
Some of the next articles are maybe not open access.
Low Density Lipoprotein Apheresis
2013Therapeutic plasma exchange volume is usually 3–5 L/session. Removal of positively charged particles as well as low density lipoprotein cholesterol improves focal segmental glomerulosclerosis and peripheral arterial disease. Angiotensin converting enzyme (ACE) inhibitors should be discontinued at least 2–3 days prior to low density ...
Kenjiro Honda, Kent Doi
openaire +1 more source
Lipoprotein Apheresis for Reduction of Lipoprotein(a)
2023Ulrich Julius, Sergey Tselmin
openaire +1 more source
Lipoprotein apheresis in pregnancy
Atherosclerosis, 2020A. Pottle, T. Khan, M. Barbir
openaire +1 more source
[Position of lipoprotein apheresis in present].
Vnitrni lekarstvi, 2016Lipoprotein apheresis (LA) is an effective treatment method the patients with severe hypercholesterolemia, resistant to the standard therapy. LA is an extracorporeal elimination technique, which specifically removes low density lipoprotein (LDL) cholesterol from the circulation.
Vladimír, Bláha +9 more
openaire +1 more source
Lipoprotein(a)-apheresis in the light of new drug developments
Atherosclerosis Supplements, 2017Elevated levels of lipoprotein(a) (Lp(a)) contribute to the risk of early and severe cardiovascular disease (CVD). Recently 60%. In some countries it is recommended in very high risk patients with early or progressive CVD. Retrospective data indicate that regular apheresis reduces cardiovascular events, which was substantiated by a recent prospective ...
openaire +2 more sources
Low-Density Lipoprotein Apheresis
Lipid-apheresis (LA) and LDL-apheresis (LDLa) are extracorporeal techniques which permit the unselective or specific removal of lipids and lipoproteins, namely Low Density Lipoproteins (LDL), as well as other apolipoprotein B100 (apoB)-containing lipoproteins from plasma -Intermediate Density Lipoproteins, Lipoprotein(a)- [IDL, Lp(a)].Sumi Hidaka, Shuzo Kobayashi
openaire +3 more sources
Lipoprotein Apheresis for Sitosterolemia
Annals of Internal Medicine, 2017Nagahiko Sakuma +4 more
openaire +1 more source
Loss of Plasma Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) After Lipoprotein Apheresis
Circulation Research, 2013Hagai Tavori +2 more
exaly
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease
Arteriosclerosis, Thrombosis, and Vascular Biology, 2016Franz Heigl +2 more
exaly